Advisor Group’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$12K Buy
2,511
+286
+13% +$1.84K ﹤0.01% 4249
2019
Q3
$12K Buy
2,225
+91
+4% +$408 ﹤0.01% 4247
2019
Q2
$6K Sell
2,134
-8,572
-80% -$29.2K ﹤0.01% 4610
2019
Q1
$44K Sell
10,706
-19,913
-65% -$126K ﹤0.01% 3483
2018
Q4
$194K Sell
30,619
-3,394
-10% -$35.2K ﹤0.01% 2113
2018
Q3
$562K Buy
34,013
+4,170
+14% +$70.9K 0.01% 1383
2018
Q2
$499K Buy
29,843
+13,291
+80% +$215K 0.01% 1308
2018
Q1
$257K Buy
16,552
+8,594
+108% +$153K ﹤0.01% 1794
2017
Q4
$151K Sell
7,958
-4,258
-35% -$94.4K ﹤0.01% 2231
2017
Q3
$358K Buy
12,216
+630
+5% +$18.6K 0.01% 1408
2017
Q2
$373K Buy
11,586
+4,147
+56% +$136K 0.01% 1337
2017
Q1
$256K Buy
7,439
+2,276
+44% +$81.3K 0.01% 1485
2016
Q4
$182K Buy
5,163
+1,207
+31% +$40.8K ﹤0.01% 1622
2016
Q3
$137K Sell
3,956
-4,028
-50% -$141K ﹤0.01% 1793
2016
Q2
$297K Buy
+7,984
New +$300K 0.01% 1210

Other funds holding ACH

Advisor Group's ACH Position: Q4 2019 in Review

Advisor Group increased its Accendra Health (ACH) stake by 13% in Q4 2019, buying an estimated $1.84K and bringing the position to 2,511 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #4249.

Advisor Group first reported a position in ACH in Q2 2016 and has held it in 15 quarters since. The position peaked at $562K in Q3 2018. 180 funds tracked by Wall St. Rank hold ACH as of Q4 2019.

  • Advisor Group held 2,511 shares of Accendra Health worth $12K as of Q4 2019.
  • Advisor Group bought 286 Accendra Health shares in Q4 2019, an estimated $1.84K.
  • Accendra Health made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4249 holding.
  • Advisor Group first reported a position in Accendra Health in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Accendra Health position peaked at $562K in Q3 2018.
  • 180 funds tracked by Wall St. Rank held Accendra Health as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.